ESElena R. Stein

Elena R. Stein

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Elena R. Stein has a total of 26 co-authors. Here are the top co-authors by number of shared publications:

  • Victoria R. Votaw

    Division of Alcohol, Drugs, and Addiction, McLean Hospital

    5 shared publications
  • Katie Witkiewitz

    Center on Alcohol, Substance Use, and Addictions, University of New Mexico

    4 shared publications
  • Katie Witkiewitz

    Department of Psychology, 1 University of New Mexico, Albuquerque, NM 87131, United States of America; Center on Alcoholism, Substance Abuse, & Addictions, 2650 Yale SE MSC11-6280, Albuquerque, NM 87106, United States of America

    3 shared publications
  • Julia E. Swan

    Department of Psychology, 1 University of New Mexico, Albuquerque, NM 87131, United States of America; Center on Alcoholism, Substance Abuse, & Addictions, 2650 Yale SE MSC11-6280, Albuquerque, NM 87106, United States of America

    2 shared publications
  • Adam D Wilson

    Department of Psychology, University of New Mexico, United States

    1 shared publication
  • Adam D. Wilson

    From the Center on Alcoholism, Substance Abuse, and Addictions (CASAA) (KW, MRP, ADW, ERS, VRV, JES, FJS) University of New Mexico Albuquerque New Mexico

    1 shared publication

Latest Publications

  • A clinical science guide for reviewing the cross-cultural rigor of assessments in an alcohol training clinic.

    by Alexandra Hernandez-Vallant, Victoria R. Votaw, Jalene L. Herron, Elena R. Stein, Julia E. Swan, Devin M. Ulrich, Meredith A. Blackwell, Barbara S. McCrady

    A standard component of service delivery in alcohol treatment clinics is evidence-based assessment (EBA). Although EBA is essential for selecting appropriate treatment modalities for alcohol use and associated problems, there are limitations in existing EBAs concerning evidence of cultural equivalence and utility among individuals seeking alcohol treatment. However, training in EBA, addictions, and clinical applications with diverse populations all are gaps in clinical training in doctoral programs in clinical psychology. The present work used the clinical science model to review the psychometric properties, cross-cultural utility, and measurement invariance of measures in an assessment battery used in an alcohol treatment training clinic. This article describes the results of that review, recommendations for retaining or replacing common assessment measures used in alcohol treatment clinics, and recommendations for alcohol treatment clinics interested in engaging in similar processes. Findings suggested that more research is needed to evaluate the psychometric properties of EBAs utilized in an alcohol treatment assessment battery, particularly among American Indian and Alaska Native people, and to test measurement invariance across race/ethnicity and other identity groups in alcohol treatment-seeking populations. Overall, routine reviews of cultural relevance are needed in clinical settings to stay current with the emerging literature. (PsycInfo Database Record (c) 2024 APA, all rights reserved).


  • Open Access

    A Longitudinal Mediation Model of Negative Emotionality, Coping Motives and Drinking Intensity Among Individuals Receiving Community Treatment for Alcohol Use Disorder

    by Victoria R Votaw, Elena R Stein, Katie Witkiewitz

    Negative emotionality is a key domain in frameworks measuring heterogeneity in alcohol use disorder (AUD), such as the Addictions Neuroclinical Assessment (ANA). Recent research has examined the construct validity of the ANA negative emotionality domain, but has not examined whether this domain demonstrates predictive validity for drinking outcomes. In this study, we examined the association between self-reported negative emotionality at baseline and drinking intensity 1 year following AUD treatment initiation. We also assessed whether coping motives for alcohol use at 6 months following treatment initiation and changes in coping motives mediated this association. This was a secondary data analysis of a multisite prospective study of individuals entering AUD treatment (n = 263; 61.6% male; mean age = 33.8). Measures of coping motives and drinking intensity captured those who experienced a lapse to drinking. The associations between the ANA negative emotionality domain, coping motives and drinking intensity over time were assessed using a latent growth curve mediation model. The ANA negative emotionality domain at baseline was indirectly associated with greater 7–12-month drinking intensity through higher coping motives at 6 months. Negative emotionality was not related to change in coping motives over the assessment period and change in coping motives was not related to 7–12-month drinking intensity. This analysis provides evidence for the predictive validity of the ANA negative emotionality domain for coping motives and drinking intensity among treatment seekers who experienced a lapse to drinking. Coping motives may be an important target in AUD treatment among those high in negative emotionality.


  • Open Access

    Can Alcohol Use Disorder Recovery Include Some Heavy Drinking? A Replication and Extension up to 9 Years Following Treatment

    by Katie Witkiewitz, Matthew R. Pearson, Adam D. Wilson, Elena R. Stein, Victoria R. Votaw, Kevin A. Hallgren, Stephen A. Maisto, Julia E. Swan, Frank J. Schwebel, Arnie Aldridge, et al.

    Background: Recent research indicates some individuals who engage in heavy drinking following treatment for alcohol use disorder fare as well as those who abstain with respect to psychosocial functioning, employment, life satisfaction, and mental health. The current study evaluated whether these findings replicated in an independent sample and examined associations between recovery profiles and functioning up to 6 years later.Methods: Data were from the 3‐year and 7‐ to 9‐year follow‐ups of subsamples initially recruited for the COMBINE study (3‐year follow‐up: n = 694; 30.1% female, 21.0% non‐White; 7‐ to 9‐year follow‐up: n = 127; 38.9% female, 27.8% non‐White). Recovery at 3 years was defined by latent profile analyses including measures of health functioning, quality of life, employment, alcohol consumption, and cannabis and other drug use. Functioning at the 7‐ to 9‐year follow‐up was assessed using single items of self‐rated general health, hospitalizations, and alcohol consumption.Results: We identified 4 profiles at the 3‐year follow‐up: (i) low‐functioning frequent heavy drinkers (13.9%), (ii) low‐functioning infrequent heavy drinkers (15.8%), (iii) high‐functioning heavy drinkers (19.4%), and (iv) high‐functioning infrequent drinkers (50.9%). At the 7‐ to 9‐year follow‐up, the 2 high‐functioning profiles had the best self‐rated health, and the high‐functioning heavy drinking profile had significantly fewer hospitalizations than the low‐functioning frequent heavy drinking profile.Conclusions: Previous findings showing heterogeneity in recovery outcomes were replicated. Most treatment recipients functioned well for years after treatment, and a subset who achieved stable recovery engaged in heavy drinking and reported good health outcomes up to 9 years after treatment. Results question the long‐standing emphasis on drinking practices as a primary outcome, as well as abstinence as a recovery criterion in epidemiologic and treatment outcome research and among stakeholder groups and funding/regulatory agencies. Findings support an expanded recovery research agenda that considers drinking patterns, health, life satisfaction, and functioning.


  • Dismantling Mindfulness-Based Programs: a Systematic Review to Identify Active Components of Treatment

    by Elena Stein, Katie Witkiewitz

    Objectives Elucidating the active ingredients of psychological treatments is an important step in the scientific validation of these interventions. Component studies are one way to test which aspects of psychological treatments impact outcomes or, in other words, are the active ingredients of treatment. As research and popular interest in mindfulness-based programs grows, it is important to evaluate the active ingredients of these programs and to continually refine theorized models of the mechanisms of mindfulness. Studying active ingredients may help clarify which elements of mindfulness-based programs are most important for dissemination. Methods We conducted a systematic review of component studies of mindfulness-based programs for adults with psychological conditions. PRISMA guidelines for systematic reviews were followed. Results Eight component studies were identified. These studies dismantled mindfulness-based stress reduction, mindfulness-based cognitive therapy, unified mindfulness, and core mindfulness processes. The eight studies differed with respect to types of programs and populations studied, yet similarities emerged. Notably, acceptance coupled with awareness and mindfulness meditation training may be two promising active ingredients of these different programs. Conclusions Future studies examining mindfulness-based programs should continue to attempt to dismantle active ingredients of treatment and use the findings to update theoretical models of mindfulness.


  • The Addictions Neuroclinical Assessment Negative Emotionality Domain Among Treatment‐Seekers with Alcohol Use Disorder: Construct Validity and Measurement Invariance

    by Victoria R. Votaw, Matthew R. Pearson, Elena Stein, Katie Witkiewitz

    Background: The Addictions Neuroclinical Assessment (ANA), a framework for measuring heterogeneity in alcohol use disorder (AUD), focuses on 3 domains that reflect neurobiological dysfunction in addiction and correspond to the cycles of addiction: executive function, incentive salience, and negative emotionality. Kwako and colleagues (Am J Psychiatry 176:744, 2019) validated a 3‐factor model of the ANA with neuropsychological and self‐report indicators among treatment‐seekers and non–treatment‐seekers with and without AUD. The present analysis replicated and extended these findings in a treatment‐seeking sample, focusing on the negative emotionality domain.Methods: Participants (n = 563; 58.8% male; mean age = 34.3) were part of a multisite prospective study of individuals entering AUD treatment. We examined the factor structure of the negative emotionality domain at the baseline, 6‐month follow‐up, and 12‐month follow‐up assessments. The Beck Depression Inventory, Beck Anxiety Inventory, State‐Trait Anger Expression Inventory‐Trait Anger Subscale, and 3 Drinker Inventory of Consequences items assessing negative affective consequences were indicators in the model.Results: Results indicated that a 1‐factor model was an excellent fit at all assessments and that the negative emotionality domain was time and gender invariant. Furthermore, negative emotionality was associated with drinking patterns and reasons for alcohol use (i.e., drinking because of negative emotions and urges/withdrawal) at all assessments.Conclusions: This analysis provides evidence for the construct validity and measurement invariance of the ANA negative emotionality domain among AUD treatment‐seekers. Future studies are needed to evaluate prospective associations between negative emotionality and specific treatment modalities, and whether individuals with greater negative emotionality are more likely to respond to treatment that targets drinking to relieve negative affective states.


  • Non-invasive brain stimulation in substance use disorders: implications for dissemination to clinical settings

    by Elena R Stein, Benjamin C Gibson, Victoria R Votaw, Adam D Wilson, Vincent P Clark, Katie Witkiewitz


  • Association of Early Stress and BDNF Genotype With Response Inhibition During Emotional Distraction in Adolescence

    by Julia E. Cohen-Gilbert, Elena R. Stein, Megan R. Gunnar, Kathleen M. Thomas

    This study investigated whether brain-derived neurotrophic factor (BDNF) genotype moderated inhibitory control during an emotionally valenced task in a sample of internationally adopted adolescents (N = 109, ages 12-13 years) who spent their early years in institutional care. Participants were genotyped for the Val66Met polymorphism of the BDNF gene. Inhibitory control in different emotional contexts was assessed via a Go-NoGo task where letters appeared at the center of positive, negative, neutral, or scrambled images. Carriers of one or more methionine (Met) alleles demonstrated a significant association between poorer performance and increased adversity, indexed by age at adoption, while valine/valine (Val/Val) carriers did not. Thus, Val/Val genotype was associated with resilience to increased impulsivity with more prolonged deprivation. These results do not converge with research suggesting differential susceptibility effects for this polymorphism, but more closely reflect a diathesis-stress model for the impact of BDNF genotype on a behavioral measure of impulsivity during emotional distraction.